1. Home
  2. FMBH vs CMPX Comparison

FMBH vs CMPX Comparison

Compare FMBH & CMPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First Mid Bancshares Inc.

FMBH

First Mid Bancshares Inc.

HOLD

Current Price

$43.25

Market Cap

951.4M

Sector

Finance

ML Signal

HOLD

Logo Compass Therapeutics Inc.

CMPX

Compass Therapeutics Inc.

HOLD

Current Price

$6.27

Market Cap

926.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FMBH
CMPX
Founded
1865
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
951.4M
926.7M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
FMBH
CMPX
Price
$43.25
$6.27
Analyst Decision
Hold
Strong Buy
Analyst Count
5
11
Target Price
$43.40
$13.44
AVG Volume (30 Days)
118.4K
2.1M
Earning Date
01-29-2026
03-18-2026
Dividend Yield
2.31%
N/A
EPS Growth
N/A
N/A
EPS
3.83
N/A
Revenue
$339,295,000.00
N/A
Revenue This Year
$8.91
N/A
Revenue Next Year
$6.82
N/A
P/E Ratio
$11.30
N/A
Revenue Growth
6.24
N/A
52 Week Low
$27.58
$1.33
52 Week High
$44.85
$6.88

Technical Indicators

Market Signals
Indicator
FMBH
CMPX
Relative Strength Index (RSI) 52.61 59.51
Support Level $42.05 $6.26
Resistance Level $44.84 $6.82
Average True Range (ATR) 1.16 0.36
MACD -0.13 -0.02
Stochastic Oscillator 47.51 61.45

Price Performance

Historical Comparison
FMBH
CMPX

About FMBH First Mid Bancshares Inc.

First Mid Bancshares Inc is a United States based financial holding company. Through its wholly-owned subsidiary, First Mid Bank, it is engaged in the business of banking. The Company offers trust, farm services, investment services, and retirement planning through its wholly owned subsidiary, it also provides data processing services to affiliates and insurance products and services to customers through its subsidiary. The company's operations cover community banking, wealth management and insurance services. Key revenue is derived from the provision of community banking services.

About CMPX Compass Therapeutics Inc.

Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to drug the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-IO Bispecific, and CTX-8371.

Share on Social Networks: